Clinical Use of Prostaglandins for Termination of Pregnancy and Induction of Labour

  • Marc Bygdeman
Part of the NATO Advanced Study Institutes Series book series (NSSA, volume 13)


Prostaglandin F2α or E2 are at present used routinely in many countries for termination of second trimester pregnancy. Recent studies indicate that some prostaglandin analogues may be practicable by more convenient routes not only in the second trimester but also during the first trimester of pregnancy. Considerable experience is also available on the clinical usefulness of intravenous administration of PGF or PGE2 and of oral administration of PGE2 for induction of labour.


Hypertonic Saline Cervical Dilatation Prostaglandin Analogue Bishop Score Vaginal Route 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    Borell, U., Bygdeman, M., Leader, A., Lundström, V. and Martin, J.N. Successful first trimester abortion following the use of 15(S)15-methyl prostaglandin F methyl ester vaginal suppositories. Contraception 13:87–94, 1976.PubMedCrossRefGoogle Scholar
  2. 2.
    Csapo, A.I. “Prostaglandin impact” for menstrual induction. Population Rept. Ser. G, No. 4, March p.p. 33–44, 1974.Google Scholar
  3. 3.
    Ragab, M.J. and Edelman, D.A. Early termination of pregnancy. A comparative study of intrauterine prostaglandin F and vacuum aspiration. Prostaglandins 11:275–285, 1976.CrossRefGoogle Scholar
  4. 4.
    Karim, S.M.M. Singapore experience with prostaglandin. Routine use and recent advances. In Obstetrics and Gynecological uses of Prostaglandins. (Ed. S.M.M. Karim) Eurasia Press, Singapore 1976, p.p. 127–154.Google Scholar
  5. 5.
    Bygdeman, M., Martin, J.N., Eneroth, P., Leader, A. and Lundström V. Outpatient postconceptional fertility control with vaginally administered 15(S)15-methyl PGF methyl ester. Am. J. Obstet. Gynecol. 124:495–498, 1976.PubMedGoogle Scholar
  6. 6.
    Bygdeman, M., Martin, J.N., Leader, A., Lundström, V., Ramadan, M., Eneroth, P. and Green, K. Early pregnancy interruption by 15(S)15-methyl prostaglandin F methyl ester. Obstet. Gynecol. 1976, in press.Google Scholar
  7. 7.
    Lundström, V., Bygdeman, M., Fotio, S. and Green, K. Abortion in early pregnancy by vaginal administration of 16,16-dimethyl PGE2. To be published, 1976.Google Scholar
  8. 8.
    Edelman, D.A., Brenner, W.E. and Goldsmith, A. Menstrual regulation in four countries. IPPF Med. Bull. Vol 8, No. 6, Dec. 1974.Google Scholar
  9. 9.
    Toppozada, M., Bygdeman, M., Papageorgiou, C. and Wiqvist, M. Administration of 15-methyl prostaglandin F as a preoperative means of cervical dilatation. Prostaglandins 4 571–379, 1973.CrossRefGoogle Scholar
  10. 10.
    Brenner, W.E., Dingfelder, J.R., Staurovsky, L.G. and Hendrichs, C. Vaginally administered PGF for cervical dilatation in nulli-paras prior to suction curettage. Prostaglandins 4:829–836, 1973.CrossRefGoogle Scholar
  11. 11.
    Wiqvist, N., Beguin, F., Bygdeman, M., Fernström, I. and Toppozada, M. Induction of abortion by extra-amniotic prostaglandin administration. Prostaglandins 1:37–53, 1972.PubMedCrossRefGoogle Scholar
  12. 12.
    Embrey, M.P., Hillier, K. and Makendran, P. Termination of pregnancy by extra-amniotic prostaglandins and the synergistic effect of oxytocin. Adv. in the Biosciences 9:507–513, 1973.Google Scholar
  13. 13.
    Bygdeman, M., Beguin, F., Toppozada, M. and Wiqvist, N. Intrauterine administration of prostaglandin F for induction of abortion. Adv. in the Biosciences 9:525–531, 1973.Google Scholar
  14. 14.
    MacKenzie, I.Z., Hillier, K. and Embrey, M.P. Single extra-amniotic injection of PGE2 in viscous gel to induce midtrimester abortion. Brit. Med. J. 1:240–242, 1974.CrossRefGoogle Scholar
  15. 15.
    Wiqvist, N., Bygdeman, M., Papageorgiou, C. and Toppozada, M. Intrauterine administration of prostaglandin by the extra-amniotic route. Prostaglandins 6:193–205, 1974.PubMedCrossRefGoogle Scholar
  16. 16.
    Green, K., Bygdeman, M. and Wiqvist, N. Kinetic and metabolic studies of prostaglandin H administered intra-amniotically for induction of abortion. Life Sciences 14:2285–2297, 1974.PubMedCrossRefGoogle Scholar
  17. 17.
    Pace-Asciak, C., Wolfe, L.S., Gillet, R.G. and Kinch, R.A. Disappearence of prostaglandin F2a from human amniotic fluid after intra-amniotic injection. Prostaglandins 1:469–477, 1972.PubMedCrossRefGoogle Scholar
  18. 18.
    WHO Prostaglandin Task Force. Comparison of intra-amniotic prostaglandin F, and hypertonic saline for induction of second trimester abortion. Brit. Med. J. 1:1371–1376, 1976.CrossRefGoogle Scholar
  19. 19.
    Karim, S.M.M., Sharma, S.D. and Filshie, G.M. Termination of second trimester pregnancy with intra-amniotic administration of prostaglandins E2 and F — In he Prostaglandins-Clinical Application in Human Reproduction (Ed. E. Southern) Futura Press, Mount Kisco, N.Y. 1972, p.p. 403–416.Google Scholar
  20. 20.
    Brenner, W.E., Dingfelder, J.R., Hendricks, C.H. and Staurovsky, L. Induction of therapeutic abortion with a single dose of intra-amniotically administered prostaglandin F. Prostaglandins 4:485–498, 1973.CrossRefGoogle Scholar
  21. 21.
    Wiqvist, N., Bygdeman, M. and Toppozada, M. Intra-amniotic prostaglandin administration — A challenge to the currently used methods for induction of midtrimester abortion. Contraception 8:113–131, 1973.PubMedCrossRefGoogle Scholar
  22. 22.
    Brenner, W.E. The current status of prostaglandins as abortifacients. Am. J. Obstet. Gynecol. 123:306–328, 1975.PubMedGoogle Scholar
  23. 23.
    Karim, S.M.M. and Amy, J.J. Interruption of pregnancy. In Prostaglandins and Reproduction (Ed. S.M.M. Karim) MTP Press Ltd. Lancaster, p.p. 78–148, 1975.Google Scholar
  24. 24.
    Wiqvist, N., Martin, J.N., Bygdeman, M. and Green, K. Prostaglandin analogues and uterotonic potency: A comparative study of seven compounds. Prostaglandins 9:255–269, 1975.PubMedCrossRefGoogle Scholar
  25. 25.
    Karim, S.M.M., Sivasamboo, R. and Ratnam, S.S. Abortifacient action of orally administered 16,16-dimethyl prostaglandin E2 and its methyl ester. Prostaglandins 6:349–354, 1974.PubMedCrossRefGoogle Scholar
  26. 26.
    Bolognese, R.J. and Corson, S.L. Prostaglandin E2 vaginal suppository as an early second trimester abortifacient. Obstet. Gynecol. 43:104–108, 1974.PubMedGoogle Scholar
  27. 27.
    Beguin, F., Bygdeman, M., Toppozada, M. and Wiqvist, N. The response of the midpregnant human uterus to vaginal administration of prostaglandin suppositories. Prostaglandins 1:397–405, 1972.PubMedCrossRefGoogle Scholar
  28. 28.
    Southern, E.M. Experience in the United States Clinical Trials of Prostaglandins in Obstetrics and Gynecology. In Obstetric and Gynecological uses of Prostaglandins. (Ed. S.M.M. Karim) Eurasia Press, Singapore 1976, p.p. 105–118.Google Scholar
  29. 29.
    Bygdeman, M. and Bergström, S. Prostaglandins as abortifacients. In Obstetric and Gynecological uses of Prostaglandins (Ed. S.M.M. Karim) Eurasia Press, Singapore 1976, p.p. 67–81.Google Scholar
  30. 30.
    Bygdeman, M., Ganguli, A., Kinoshita, K., Lundström, V., Green, K. and Bergström, S. Development of a vaginal suppository suitable for single administration for interruption of second trimester pregnancy. Contraception. In press.Google Scholar
  31. 31.
    Karim, S.M.M., Trussel, R.R., Patel, R.C. and Hillier, K. Response of pregnant human uterus to prostaglandin F2a induction of labours. Brit. Med. J. 4:621–623, 1968.PubMedCrossRefGoogle Scholar
  32. 32.
    Thiery, M. and Amy, J.J. Induction of labour with Prostaglandins. In Prostaglandins and Reproduction (Ed. S.M.M. Karim). MTP Press Ltd, Lancaster 1975, p.p. 149–229.Google Scholar
  33. 33.
    Ande rsson, G.G., Hobbins, J.C., Speroff, L. and Caldwell, B.V. Intravenous prostaglandins E2 and F2a and syntocinon for the induction of term labour. In The Prostaglandins Clinical Applications in Human Reproduction (Ed. E.M. Southern) Futura Press, Mount Kisco, N.Y. 1972, p.p. 85–94.Google Scholar
  34. 34.
    Vakhariya, V.R. and Sherman, A.I. Prostaglandin F2a for induction of labour. Amer. J. Obstet. Gynecol. 113:212–222, 1972.Google Scholar
  35. 35.
    Spellacy, W.N., Gall, S.A., Shevach, A.B. and Holsinger, K.K. The induction of labor at term. Comparisons between prostaglandin F2a and oxytocin infusions. Obstet. Gynecol. 41:14–21, 1973.PubMedGoogle Scholar
  36. 36.
    Karim, S.M.M., Patel, R.C., Sharma, S.D. and Trussel, R.R. Two years experience of labour J. Asian Fed. Obstet. Gynaecol. 2:1–6, 1971.Google Scholar
  37. 37.
    Beazley, J.M. and Gillespie, A. Double blind trial of prostaglandin Eo and oxytocin in induction of labour. Lancet 1:152–155, 1971.PubMedCrossRefGoogle Scholar
  38. 38.
    Brown, A.A., Hamlett, J.D., Hibbard, M.B. and Howe, P.D. Induction of labour by amniotomy and intravenous infusion of oxytocic drugs — A comparison between prostaglandins and oxytocin. J. Obstet. Gynaecol. Brit. Cmwlth 80:111–115, 1973.CrossRefGoogle Scholar
  39. 39.
    Karim, S.M.M. and Sharma, S.O. Oral administration of prostaglandin E2 for the induction of acceleration of labour. In The Prostaglandins Clinical Applications in Human Reproduction. (Ed. E.M. Southern) Futura Press, Mount Kisco, N.Y. p.p. 207–217, 1972.Google Scholar
  40. 40.
    Craft, I.L. Oral prostaglandin E2 and amniotomy for induction of labor. Adv. Biosciences 9:593–598, 1973.Google Scholar
  41. 41.
    Filshie, G.M. Labor induction with oral prostaglandin E2. In The Prostaglandins Clinical Applications in Human Reproduction (Ed. E.M. Southern) Futura Press, Mount Kisco, N.Y. p.p. 223–226, 1972.Google Scholar
  42. 42.
    Thiery, M., Yo Le Gian, A., de Hemptinne, D., Derom, R., Martens, G., Vankets, J. and Amy, J.J. Induction of labour with prostaglandin E2 tablets. J. Obstet. Gynaecol. Brit. Cmwlth. 81:303–306, 1974.CrossRefGoogle Scholar
  43. 43.
    Elder, M.G. and Stone, M. Induction of labour by low amniotomy and oral administration of a solution compared to a tablet of prostaglandin E2. Prostaglandins 6:427–432, 1974.PubMedCrossRefGoogle Scholar
  44. 44.
    Barr, W. Induction of labour by prostaglandin E2. In The Prostaglandins Clinical Applications in Human Reproduction. (Ed. E.M. Southern) Futura Press, Mount Kisco, N.Y. p.p. 219–222, 1972.Google Scholar
  45. 45.
    Thiery, M. Elective induction of labour at term with oxytocin and prostaglandins. Techniques and fetal and maternal effects. In Avortement et Parturition Provoqués (Eds. M.J. Bose, R. Palmer and C. Surean) Masson, Paris p.p. 267–287, 1974.Google Scholar
  46. 46.
    Thiery, M. and Amy, J.J. Recinatal effects of prostaglandin used for induction of labour. In Obstetric and Gynecological uses of prostaglandins (Ed. S.M.M. Karim) Eurasia Press, Singapore p.p. 31–54, 1976.Google Scholar

Copyright information

© Plenum Press, New York 1977

Authors and Affiliations

  • Marc Bygdeman
    • 1
  1. 1.Department of Obstetrics and GynecologyKarolinska HospitalStockholmSweden

Personalised recommendations